These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4654564)

  • 21. [Cardiovascular effects of glucagon].
    Gavrilescu S; Streian C
    Med Interna (Bucur); 1972 Apr; 24(4):441-50. PubMed ID: 5027789
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucagon in congestive heart failure.
    Kones RJ; Phillips JH
    Chest; 1971 Apr; 59(4):392-7. PubMed ID: 5551583
    [No Abstract]   [Full Text] [Related]  

  • 23. [The cardiotonic effect of glucagon. Clinical study and therapeutic indications].
    Inzoli MR; Almici C
    Minerva Med; 1973 Dec; 64(87):4604-9. PubMed ID: 4774228
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative biological actions of different depot glucagons and standard glucagon].
    Assan R; Delaunay J
    Pathol Biol (Paris); 1972 Dec; 20(23):979-84. PubMed ID: 4568037
    [No Abstract]   [Full Text] [Related]  

  • 25. Glucagon: its enhancement of cardiac performance in the cat with chronic heart failure.
    Nobel-Allen N; Kirsch M; Lucchesi BR
    J Pharmacol Exp Ther; 1973 Dec; 187(3):475-81. PubMed ID: 4770394
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior of various endocrine and metabolic parameters in heart patients treated with glucagon].
    Gragnoli G; Martinelli G; Nami R; Tanganelli I; Favilli R; Palazzuoli V; pallassini A
    Boll Soc Ital Cardiol; 1976; 21(5):834-55. PubMed ID: 1031051
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cardiotonic effect of glucagon].
    Robert M; Humair L
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:123-6. PubMed ID: 5288597
    [No Abstract]   [Full Text] [Related]  

  • 28. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
    Nikolaidis LA; Elahi D; Hentosz T; Doverspike A; Huerbin R; Zourelias L; Stolarski C; Shen YT; Shannon RP
    Circulation; 2004 Aug; 110(8):955-61. PubMed ID: 15313949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained effect of zinc-protamin-glucagon in hyperlipidaemic patients.
    Buch J; Buch A
    Acta Pharmacol Toxicol (Copenh); 1983 Sep; 53(3):188-92. PubMed ID: 6637508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of glucagon therapy in heart failure.
    Congdon EE; Vixie DK; Wright MF
    J Am Osteopath Assoc; 1970 Jul; 69(11):1114-7. PubMed ID: 5202393
    [No Abstract]   [Full Text] [Related]  

  • 31. [Glucagon. A new cardioactive drug].
    Guerricchio G
    Minerva Med; 1974 Oct; 65(72):3799-803. PubMed ID: 4607692
    [No Abstract]   [Full Text] [Related]  

  • 32. Glucagon therapy in heart-failure.
    Brogan E; Kozonis MC; Overy DC
    Lancet; 1969 Mar; 1(7593):482-4. PubMed ID: 4179568
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative effects of glucagon injection in normal-weight and obese nondiabetic subjects. Preliminary report].
    Scornavachi JC; Vague P; Rouvier-Leroy C
    Diabete; 1968; 16(2):126-31. PubMed ID: 4923394
    [No Abstract]   [Full Text] [Related]  

  • 34. Glucagon? One answer to cardiogenic shock.
    Deraney MF
    Am J Med Sci; 1971 Mar; 261(3):149-54. PubMed ID: 4326665
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of glucagon on the systolic time interval and on cyclic-AMP plasma concentration in patients with chronic myocardial insufficiency].
    Jaeschke M; Kuhn H; Breithardt G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():421. PubMed ID: 207040
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of glucagon in small doses and reinfusion of desalted and concentrated ascitic fluid in the therapy of refractory cardiac decompensation].
    Vancini B; Govoni P; Caio M
    Boll Soc Ital Cardiol; 1974; 19(4):401-7. PubMed ID: 4464944
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic congestive heart failure treated with long-term infusion of glucagon.
    Forfang K; Falch D; Frey HM; Fremstad D
    Acta Med Scand; 1973 Dec; 194(6):563-6. PubMed ID: 4773458
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of glucagon on serum bilirubin levels.
    Constantopoulos A; Davakis M; Malamitsi-Pouchner A; Matsaniotis N
    Cytobios; 1982; 35(138):103-11. PubMed ID: 7160224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of glucagon in cardiology].
    Todorova M
    Vutr Boles; 1974; 13(1):13-8. PubMed ID: 4611029
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biochemical and haemodynamic effects of zinc-protamin-glucagon in man (author's transl)].
    Kühn P; Holzhey P; Niederberger M; Fritzsche H; Kroiss A; Brenner B; Kaindl F
    Klin Wochenschr; 1973 Oct; 51(19):951-6. PubMed ID: 4762583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.